Differential vulnerabilities of substantia nigra catecholamine neurons to excitatory amino acid-induced degeneration in rat midbrain slices

Experimental Neurology

Volumn 162, Issue 1, 2000, Pages 180-188

  Bywood, Petra T ^a   Johnson, Stephen M ^a  

^a FLINDERS UNIVERSITY   (Australia)

Author keywords

Brain slice; Catecholamine; Dendrite degeneration; Excitatory amino acid; Selective vulnerability; Substantia nigra

Indexed keywords

CATECHOLAMINE; EXCITATORY AMINO ACID;

ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DEGENERATIVE DISEASE; DENDRITE; IMMUNOHISTOCHEMISTRY; MALE; MESENCEPHALON; NERVE CELL DEGENERATION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

EID: 0034024373     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7310     Document Type: Article

References (46)

1. Agid Y., Ruberg M., Javoy-Agid F., Hirsch E., Raisman-Vozari R., Vyas S., Faucheux B., Michel P., Kastner A., Blanchard V. Are dopaminergic neurons selectively vulnerable to Parkinson's disease. Adv. Neurol. 60:1993;148-164.
2. Beal M. F. Role of excitotoxicity in human neurological disease. Curr. Opin. Neurobiol. 2:1992;657-662.
3. Bennett J. P. Antipsychotic agents. Brody T. M., Larner J., Minneman K. P., Neu H. C. Human Pharmacology. 1994;321-331 Mosby YearBook, Sydney.
4. Bywood P. T., Johnson S. M. Dendrite loss is a characteristic early indicator of toxin-induced neurodegeneration in rat midbrain slices. Exp. Neurol. 161:1999;306-316.
5. Cerruti C., Drian M. J., Kamenka J. M., Privat A. Protection by BTCP of cultured dopaminergic neurons exposed to neurotoxins. Brain Res. 617:1993;138-142.
6. Chan-Palay V. Alterations in the locus coeruleus in dementias of Alzheimer's and Parkinson's disease. Prog. Brain Res. 88:1991;625-630.
7. Chan-Palay V., Asan E. Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression. J. Comp. Neurol. 287:1989;373-392.
8. Cubells J. F., Rayport S., Rajendran G., Sulzer D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J. Neurosci. 14:1994;2260-2271.
9. Damier P., Hirsch E. C., Agid Y., Graybiel A. M. The substantia nigra of the human brain: II. Patterns of loss of dopamine-containing neurons in Parkinson's disease. Brain. 122:1999;1437-1448.
10. Edwards R. H. Neural degeneration and the transport of neurotransmitters. Ann. Neurol. 34:1993;638-645.
11. Feig S., Lipton P. N-Methyl-d-aspartate receptor activation and Ca2+ account for poor pyramidal cell structure in hippocampal slices. J. Neurochem. 55:1990;473-483.
12. Garthwaite G., Garthwaite J. Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: Dependence on calcium concentration. Neurosci. Lett. 66:1986;193-198.
13. German D. C., Manaye K. F., Sonsalla P. K., Brooks B. A. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: Sparing of calbindin-D28k-containing cells. Ann. N.Y. Acad. Sci. 648:1992;42-62.
14. German D. C., Nelson E. L., Liang C. L., Speciale S. G., Sinton C. M., Sonsalla P. K. The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse. Neurodegeneration. 5:1996;299-312.
15. Herrero M. T., Hirsch E. C., Kastner A., Ruberg M., Luquin M. R., Laguna J., Javoy-Agid F., Obeso J. A., Agid Y. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP. Neuroscience. 56:1993;499-511.
16. Hirsch E. C., Graybiel A. M., Agid Y. Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease. Acta Neurol. Scand. Suppl. 126:1989;19-22.
17. Irving E. A., McCulloch J., Dewar D. Intracortical perfusion of glutamate in vivo induces alterations of tau and microtubule-associated protein 2 immunoreactivity in the rat. Acta Neuropathol. (Berl.). 92:1996;186-196.
18. Isaacs K. R., de Erausquin G., Strauss K. I., Jacobowitz D. M., Hanbauer I. Differential effects of excitatory amino acids on mesencephalic neurons expressing either calretinin or tyrosine hydroxylase in primary cultures. Brain Res. Mol. Brain Res. 36:1996;114-126.
19. Isaacs K. R., Wolpoe M. E., Jacobowitz D. M. Calretinin-immunoreactive dopaminergic neurons from embryonic rat mesencephalon are resistant to levodopa-induced neurotoxicity. Exp. Neurol. 146:1997;25-32.
20. Jackson-Lewis V., Jakowec M., Burke R. E., Przedborski S. Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration. 4:1995;257-269.
21. Johnson S. M., Bywood P. T. Degeneration of the dendritic arbor as an index of neurotoxicity in identified catecholamine neurons in rat brain slices. Exp. Neurol. 151:1998;221-228.
22. Johnson S. M., Bywood P. T. Excitatory amino acid-induced degeneration of dendrites of catecholamine neurons in rat substantia nigra. Exp. Neurol. 151:1998;229-236.
23. Johnson S. M., Trussell D. C., McRitchie D. A., Halliday G. M., Hardman C. D. Anatomical and immunohistochemical identification of catecholaminergic neurons in brain slice preparations used in electrophysiology. J. Neurosci. Methods. 64:1996;83-93.
24. Kikuchi S., Kim S. U. Glutamate neurotoxicity in mesencephalic dopaminergic neurons in culture. J. Neurosci. Res. 36:1993;558-569.
25. Kostrzewa R. M., Brus R. Destruction of catecholamine-containing neurons by 6-hydroxydopa, an endogenous amine oxidase cofactor. Amino Acids. 14:1998;175-179.
26. Marcyniuk B., Mann D. M., Yates P. O. Loss of nerve cells from locus coeruleus in Alzheimer's disease is topographically arranged. Neurosci. Lett. 64:1986;247-252.
27. Marttila R. J., Rinne U. K. Progression and survival in Parkinson's disease. Acta Neurol. Scand. Suppl. 136:1991;24-28.
28. Masalha R., Herishanu Y., Alfahel-Kakunda A., Silverman W. F. Selective dopamine neurotoxicity by an industrial chemical: An environmental cause of Parkinson's disease. Brain Res. 774:1997;260-264.
29. Matesic D. F., Lin R. C. Microtubule-associated protein 2 as an early indicator of ischemia-induced neurodegeneration in the gerbil forebrain. J. Neurochem. 63:1994;1012-1020.
30. Mateu G., Privat A., Thibault J., Vignon J. Comparison of glutamate and N-methyl-d-aspartate toxicities on rat mesencephalic primary cell cultures. Int. J. Dev. Neurosci. 15:1997;851-865.
31. McRitchie D. A., Halliday G. M., Cartwright H. Quantitative analysis of the variability of substantia nigra pigmented cell clusters in the human. Neuroscience. 68:1995;539-551.
32. Merad-Boudia M., Nicole A., Santiard-Baron D., Saille C., Ceballos-Picot I. Mitochondrial impairment as an early event in the process of apoptosis induced by glutathione depletion in neuronal cells: relevance to Parkinson's disease. Biochem. Pharmacol. 56:1998;645-655.
33. Olney J. W. Excitotoxic mechanisms of neurotoxicity. Spencer P. S., Schaumburg H. H. Experimental and Clinical Neurotoxicology. 1980;272-294 Williams & Wilkins, Baltimore.
34. Parent A., Lavoie B. The heterogeneity of the mesostriatal dopaminergic system as revealed in normal and parkinsonian monkeys. Adv. Neurol. 60:1993;25-33.
35. Park J. S., Bateman M. C., Goldberg M. P. Rapid alterations in dendrite morphology during sublethal hypoxia or glutamate receptor activation. Neurobiol. Dis. 3:1996;215-227.
36. Politis M. J., Schaumburg H. H., Spencer P. S. Neurotoxicity of selected chemicals. Spencer P. S., Schaumburg H. H. Experimental and Clinical Neurotoxicology. 1980;613-630 Williams & Wilkins, Baltimore.
37. Portera-Cailliau C., Price D. L., Martin L. J. Excitotoxic neuronal death in the immature brain is an apoptosis-necrosis morphological continuum. J. Comp. Neurol. 378:1997;70-87.
38. Reuhl, K. R., and H. E. Lowndes. 1992. Factors influencing morphological expression of neurotoxicity. In NeurotoxicologyH. Tilson and C. Mitchell, Eds., pp. 67-81. Raven Press, New York.
39. Rice M. E., Perez-Pinzon M. A., Lee E. J. Ascorbic acid, but not glutathione, is taken up by brain slices and preserves cell morphology. J. Neurophysiol. 71:1994;1591-1596.
40. Sanchez-Ramos J. R., Michel P., Weiner W. J., Hefti F. Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: Cytochemical and morphological evidence. J. Neurochem. 50:1988;1934-1944.
41. Sanghera M. K., Manaye K., McMahon A., Sonsalla P. K., German D. C. Dopamine transporter mRNA levels are high in midbrain neurons vulnerable to MPTP. Neuroreport. 8:1997;3327-3331.
42. Sawada H., Kawamura T., Shimohama S., Akaike A., Kimura J. Different mechanisms of glutamate-induced neuronal death between dopaminergic and non-dopaminergic neurons in rat mesencephalic culture. J. Neurosci. Res. 43:1996;503-510.
43. Schurr A., Payne R. S., Heine M. F., Rigor B. M. Hypoxia, excitotoxicity, and neuroprotection in the hippocampal slice preparation. J. Neurosci. Methods. 59:1995;129-138.
44. Uhl G. R. Hypothesis: The role of dopaminergic transporters in selective vulnerability of cells in Parkinson's disease. Ann. Neurol. 43:1998;555-560.
45. Yamada T., McGeer P. L., Baimbridge K. G., McGeer E. G. Relative sparing in Parkinson's disease of substantia nigra dopamine neurons containing calbindin-D28K. Brain Res. 526:1990;303-307.
46. Zeevalk G. D., Bernard L. P., Sinha C., Ehrhart J., Nicklas W. J. Excitotoxicity and oxidative stress during inhibition of energy metabolism. Dev. Neurosci. 20:1998;444-453.